Difficulty: Medium
Average Score: 78%
Practice
A client with cystic fibrosis is prescribed dornase alfa (Pulmozyme). What is the primary therapeutic goal of this medication?
Correct answer
B
Rationale
The primary therapeutic goal of dornase alfa (Pulmozyme) in cystic fibrosis is to thin and loosen mucus secretions. This enzyme helps break down the DNA in thick, sticky mucus, making it easier for the patient to clear their airways. By thinning the mucus, it reduces the risk of blockages, improves airway clearance, and enhances lung function. This directly addresses the underlying issue in cystic fibrosis, which is the buildup of thick mucus in the lungs.
Other choices are incorrect because:
A: While dornase alfa may indirectly help reduce lung inflammation by improving mucus clearance, its primary goal is not to directly reduce inflammation.
C: While dornase alfa may reduce the risk of infections by improving mucus clearance, its primary goal is not to prevent bacterial infections.
D: While improved mucus clearance may indirectly help with oxygen absorption, the primary goal of dornase alfa is specifically to
Other choices are incorrect because:
A: While dornase alfa may indirectly help reduce lung inflammation by improving mucus clearance, its primary goal is not to directly reduce inflammation.
C: While dornase alfa may reduce the risk of infections by improving mucus clearance, its primary goal is not to prevent bacterial infections.
D: While improved mucus clearance may indirectly help with oxygen absorption, the primary goal of dornase alfa is specifically to